Publicacións en colaboración con investigadores/as de University College London Hospitals NHS Foundation Trust (1)

2016

  1. Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): A randomised, double-blind, placebo-controlled phase 3 trial

    The Lancet, Vol. 387, Núm. 10023, pp. 1066-1074